iBio (IBIO) EBT Margin Growth (5y) (2016 - 2025)
iBio (IBIO) EBT Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn |
| 10 | iBio | 166.24 Mn | 166.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -388,244.00 |
| Jun 30, 2025 | -222,984.00 |
| Dec 31, 2024 | -102,464.00 |
| Jun 30, 2024 | -109,220.00 |
| Sep 30, 2023 | -35,689.00 |
| Mar 31, 2022 | 1.15 Mn |
| Sep 30, 2021 | -4.16 Mn |
| Jun 30, 2021 | 827,842.00 |
| Mar 31, 2021 | -10,724.00 |
| Dec 31, 2020 | 52,741.00 |
| Sep 30, 2020 | -70,569.00 |
| Jun 30, 2020 | 28,289.00 |
| Mar 31, 2020 | -442,270.00 |
| Dec 31, 2019 | -51,053.00 |
| Sep 30, 2019 | -395,215.00 |
| Jun 30, 2019 | -682.00 |
| Jun 30, 2018 | -464,184.00 |
| Sep 30, 2017 | -267,816.00 |
| Jun 30, 2017 | -233,223.00 |
| Mar 31, 2017 | -1.13 Mn |